Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2006

Open Access 01-12-2006 | Research article

Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders

Authors: Prasenjit Manna, Mahua Sinha, Parames C Sil

Published in: BMC Complementary Medicine and Therapies | Issue 1/2006

Login to get access

Abstract

Background

Carbon tetrachloride (CCl4) is a well-known hepatotoxin and exposure to this chemical is known to induce oxidative stress and causes liver injury by the formation of free radicals. Acute and chronic renal damage are also very common pathophysiologic disturbances caused by CCl4. The present study has been conducted to evaluate the protective role of the aqueous extract of the bark of Termnalia arjuna (TA), an important Indian medicinal plant widely used in the preparation of ayurvedic formulations, on CCl4 induced oxidative stress and resultant dysfunction in the livers and kidneys of mice.

Methods

Animals were pretreated with the aqueous extract of TA (50 mg/kg body weight) for one week and then challenged with CCl4 (1 ml/kg body weight) in liquid paraffin (1:1, v/v) for 2 days. Serum marker enzymes, namely, glutamate pyruvate transaminase (GPT) and alkaline phosphatase (ALP) were estimated in the sera of all study groups. Antioxidant status in both the liver and kidney tissues were estimated by determining the activities of the antioxidative enzymes, superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST); as well as by determining the levels of thiobarbutaric acid reactive substances (TBARS) and reduced glutathione (GSH). In addition, free radical scavenging activity of the extract was determined from its DPPH radical quenching ability.

Results

Results showed that CCl4 caused a marked rise in serum levels of GPT and ALP. TBARS level was also increased significantly whereas GSH, SOD, CAT and GST levels were decreased in the liver and kidney tissue homogenates of CCl4 treated mice. Aqueous extract of TA successfully prevented the alterations of these effects in the experimental animals. Data also showed that the extract possessed strong free radical scavenging activity comparable to that of vitamin C.

Conclusion

Our study demonstrated that the aqueous extract of the bark of TA could protect the liver and kidney tissues against CCl4-induced oxidative stress probably by increasing antioxidative defense activities.
Appendix
Available only for authorised users
Literature
1.
Halliwell B: Oxygen Species in Pathology with Special Reference to the Skin. Oxidative Stress in Dermatology. 1993, Marcel Dekker, Inc., New York, 3-11.
2.
Oberley LW: Free radicals and diabetes. Free Radical Biol Med. 1988, 5: 113-124. 10.1016/0891-5849(88)90036-6.CrossRef
3.
4.
Sarkar K, Ghosh A, Kinter M, Mazumder B, Sil PC: Purification and characterization of a 43 kD hepatoprotective protein from the herb Cajanus indicus L. Protein J. 2006,
5.
Abraham P, Wilfred G, Cathrine SP: Oxidative damage to the lipids and proteins pf the lungs, testis and kidney of rats during carbon tetrachloride intoxication. Clin Chim Acta. 1999, 289: 177-179. 10.1016/S0009-8981(99)00140-0.CrossRefPubMed
6.
Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, Slomka M, Madro A, Celinski K, Wielosz M: Catalase, superoxide dismutase and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg. 2003, 10: 309-315. 10.1007/s00534-002-0824-5.CrossRefPubMed
7.
Guven A, Guven A, Gulmez M: The effect of kefir on the activities of GSH- Px,GST,CAT,GSH and LPO levels in carbon tetrachloride-induced mice tissue. J Vet Med B Infect Dis Vet Public Health. 2003, 50: 412-416.CrossRefPubMed
8.
Charbonneau M, Brodeur J, Du Souich P, Plaa GL: Correlation between acetone-potentiated CCl4-induced liver injury and blood concentrations after inhalation or oral administration. Toxicol Appl Pharmacol. 1986, 84: 286-294. 10.1016/0041-008X(86)90136-5.CrossRefPubMed
9.
Ahmad FF, Cowan DL, Sun AY: Detection of free radical formation in various tissues after acute carbon tetrachloride administration in gerbil. Life Sci. 1987, 41: 2469-2475. 10.1016/0024-3205(87)90673-4.CrossRefPubMed
10.
Ohta Y, Nishida K, Sasaki E, Kongo M, Ishiguro I: Attenuation of disrupted hepatic active oxygen metabolism with the recovery of acute liver injury in rats intoxicated with carbon tetrachloride. Res Commun Mol Pathol Pharmacol. 1997, 95: 191-207.PubMed
11.
Ozturk F, Ucar M, Ozturk IC, Vardi N, Batcioglu K: Carbon tetrachloride-induced nephrotoxicity and protective effect of betaine in Sprague-Dawley rats. Urology. 2003, 62: 353-356. 10.1016/S0090-4295(03)00255-3.CrossRefPubMed
12.
Perez AJ, Courel M, Sobrado J, Gonzalez L: Acute renal failure after topical application of carbon tetrachloride. Lancet. 1987, 1: 515-516.CrossRef
13.
Ogeturk M, Kus I, Colakoglu N, Zararsiz I, Ilhan N, Sarsilmaz M: Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. J Ethnopharmacol. 2005, 97: 273-280. 10.1016/j.jep.2004.11.019.CrossRefPubMed
14.
Churchill DN, Finn A, Gault M: Association between hydrocharbon exposure and glomerulonephritis. An araisal of the evidence. Nephron. 1983, 33: 169-172.CrossRefPubMed
15.
Ruprah H, Mant TGK, Flanagan RJ: Acute carbon tetrachloride poisoning in19 pateints:implications for diagnosis and treatment. Lancet. 1985, 1: 1027-1029. 10.1016/S0140-6736(85)91624-1.CrossRefPubMed
16.
Gosselin RE, Smith RP, Hodge HC: Clinical toxicology of commercial products. 1984, Williams and Wilkins, Baltimore, MD, 5
17.
Yoshikawa T, Furukawa Y, Murakami M, Takemura S, Kondo M: Effect of viatmin E on D-Galactosamine-induced or carbon tetrachloride-induced hepatotoxicity. Digestion. 1982, 25: 222-229.CrossRefPubMed
18.
Weber LW, Boll M, Stampfl A: Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003, 33: 105-136.CrossRefPubMed
19.
Ko KM, Ip SP, Poon MK, Wu SS, Che CT, Ng KH, Kong YC: Effect of a lignan-enriched fructus schisandrae extract on hepatic glutathione status in rats:protection against carbon tetrachloride toxicity. Planta Med. 1995, 61: 134-137.CrossRefPubMed
20.
Rajesh MG, Latha MS: Protective activity of Glycyrrhiza glabra Linn. on Carbon tetrachloride-induced peroxidative damage. Indian J Pharmacol. 2004, 36: 284-287.
21.
de Mejia EG, Ramirez-Mares MV: Leaf extract from Ardisia compressa protects against 1-nitropyrene-induced cytotoxicity and its antioxidant defense disruption in cultured rat hepatocytes. Toxicology. 2002, 179: 151-162. 10.1016/S0300-483X(02)00242-1.CrossRefPubMed
22.
Iwu MM, Jackson JE, Schuster BG: Medicinal plants in the fight against leishmaniasis. Parasitol. Today. 1994, 10: 65-68.
23.
Chopra RN, Nayar SL, Chopra IC: Glossary of Indian Medicinal Plants. 1986, Publication and Information Directorate, CSIR, New Delhi, 44-46.
24.
Russo A, Izzo AA, Cardile V, Borrelli F, Vanella A: Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine. 2001, 8: 125-132. 10.1078/0944-7113-00021.CrossRefPubMed
25.
Murthy MSR, Srinivasan M: Hepatoprotective effect of Tephrosia purpurea in experimental animals. Ind J Pharmacology. 1993, 25: 34-36.
26.
Farghali H, Kamenikova L, Hynie S, Kmonickova E: Silymarin effects on intracellular calcium and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res. 2000, 41: 231-237. 10.1006/phrs.1999.0575.CrossRefPubMed
27.
Chauhan CK, Nanivadekar SA, Billimoria FR: Effect of a herbal hepatoprotective product on drug metabolism in patients of cirrhosis and hepatic enzyme function in experimental liver damage. Ind J Pharmacol. 1992, 24: 107-110.
28.
Ghosh A, Biswas K: Bhartiya Banausadhi. Edited by: Chatterjee A. 1973, Calcutta University Press, Calcutta, 2: 332-334.
29.
Kirtikar KR, Basu BD, Blatter E, Caius JF, Mhaskarr RS, (Eds): Indian Medicinal Plants. 1935, Probasi Press, Calcutta, I: 809-811.
30.
Syamasundar KV, Singh B, Thakur RS, Husain A, Kiso Y, Hikino H: Antihepatotoxic principles of Phyllanthus niruri herbs. J Ethnopharmacol. 1985, 14: 41-44. 10.1016/0378-8741(85)90026-1.CrossRefPubMed
31.
Venkateswaran PS, Millman I, Blumberg BS: Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci U S A. 1987, 84: 274-278. 10.1073/pnas.84.1.274.CrossRefPubMedPubMedCentral
32.
Unander DW, Webster GL, Blumberg BS: Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. J Ethnopharmacol. 1995, 45: 1-18. 10.1016/0378-8741(94)01189-7.CrossRefPubMed
33.
Karthikeyan K, Sarala Bai BR, Gauthaman K, Sathish KS, Niranjali Devaraj S: Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci. 2003, 73: 2727-2739. 10.1016/S0024-3205(03)00671-4.CrossRefPubMed
34.
Dwivedi S, Jauhari R: Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J. 1997, 49: 507-510.PubMed
35.
Bharani A, Ganguly A, Bhargava KD: Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol. 1995, 49: 191-199. 10.1016/0167-5273(95)02320-V.CrossRefPubMed
36.
Ram A, Lauria P, Gupta R, Kumar P, Sharma VN: Hypocholesterolaemic effects of Terminalia arjuna tree bark. J Ethnopharmacol. 1997, 55: 165-169. 10.1016/S0378-8741(96)01493-6.CrossRefPubMed
37.
Alternative medicine review. 1997, 4: 436-437.
38.
Bone K: Clinical Application of Ayurvedic and Chinese Herbs. 1996, Warwick, Queensl, Australia, Phytotherapy Press, 131-133.
39.
Kapoor LD: Handbook of Ayurvedic Medicinal Plants. 1990, Boca Raton, FL. CRC Press, 319-320.
40.
Blois MS: Antioxidant determination by use of a stable free radical. Nature. 1958, 29: 1199-1200. 10.1038/1811199a0.CrossRef
41.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.CrossRefPubMed
42.
Reitman S, Frankel S: A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957, 28: 56-63.CrossRefPubMed
43.
44.
Nishikimi M, Rao NA, Yagi K: The occurrence of superoxide anion in the reaction of reduced phenazine methosulphate and molecular oxygen. Biochem Biophys Res Commun. 1972, 46: 849-854. 10.1016/S0006-291X(72)80218-3.CrossRefPubMed
45.
Kakkar P, Das B, Viswanathan PN: A Modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys. 1984, 21: 130-132.
46.
Bonaventura J, Schroeder WA, Fang S: Human erythrocyte catalase: an improved method of isolation and a revalution of reported properties. Arch Biochem Biophys. 1972, 150: 606-617. 10.1016/0003-9861(72)90080-X.CrossRefPubMed
47.
Habig WH, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974, 249: 7130-7139.PubMed
48.
Ellman GL: Tissue sulfhydryl group. Arch Biochem Biophys. 1959, 82: 70-77. 10.1016/0003-9861(59)90090-6.CrossRefPubMed
49.
Esterbauer H, Cheesman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186: 407-421.CrossRefPubMed
50.
Noguchi T, Fong KL, Lai EK, Alexander SS, King MM, Olson L, Poyer JL, Mccay PB: Specificity of aphenobarbital-induced cytochrome P450 for metabolism of carbontetrachloride to the trichloromethyl radical. Biochem Pharmacol. 1982, 31: 615-624. 10.1016/0006-2952(82)90440-3.CrossRefPubMed
51.
Packer JE, Slater TF, Willson RL: Reactions of the carbon tetrachlonde-related peroxy free radical with aminoacids: pulse radiolysis evidence. Life Sci. 1978, 23: 2617-2620. 10.1016/0024-3205(78)90378-8.CrossRefPubMed
52.
Recknagel RO, Glendek EA, Dolazk JA, Waller RL: Mechanism of carbon tetrachloride toxicity. Pharmacol Ther. 1989, 43: 139-154. 10.1016/0163-7258(89)90050-8.CrossRefPubMed
53.
Tom WM, Fong D, Woo B, Prasongwatana V, Boyde TR: Microsomal lipid peroxidation and oxidative metabolism in rat liver. Chem Biol Interact. 1984, 50: 361-363. 10.1016/0009-2797(84)90043-7.CrossRefPubMed
54.
Halliwell B, Gutteridge JMC: Free radicals in Biology and medicine. 2000, Oxford University Press, 148-149.
55.
Yamamoto Y, Yamashita S: Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion. BioFactors. 1999, 9: 241-245.CrossRefPubMed
56.
Stal P, Olson J: Ubiquinone: Oxidative stress, and liver carcinogenesis. Coenzyme Q: Molecular Mechanisms in Health and Disease. Edited by: Kagan Ve, Quinn DJ. 2000, CRC Press, Boca Raton, 317-329.CrossRef
57.
Tirkey N, Pilkhwal S, Kuhad A, Chopra K: Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol. 2005, 5: 2-10.1186/1471-2210-5-2.CrossRefPubMedPubMedCentral
58.
Bandhopadhy U, Das D, Banerjee KR: Reactive oxygen species: Oxidative damage and pathogenesis. Curr Sci. 1999, 77: 658-665.
59.
Tabatabaie T, Floyd RA: Susceptibility of glutathione peroxidase and glutathione reductase to oxidative damage and the protective effect of spin trapping agents. Arch Biochem Biophys. 1994, 314: 112-119. 10.1006/abbi.1994.1418.CrossRefPubMed
60.
Anandan R, Deepa Rekha R, Devaki T: Protective effect of Picrorrhiza Kurroa on mitochondrial glutathione antioxidant systems in D-galactosamine induced hepatitis in rats. Curr Sci. 1999, 76: 1543-1545.
61.
Noguchi T, Fong KL, Lai EK, Alexander SS, King MM, Olson L, Poyer JL, Mccay PB: Specificity of aphenobarbital-induced cytochrome P450 for metabolism of carbontetrachloride to the trichloromethyl radical. Biochem Pharmacol. 1982, 31: 615-624. 10.1016/0006-2952(82)90440-3.CrossRefPubMed
Metadata
Title
Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders
Authors
Prasenjit Manna
Mahua Sinha
Parames C Sil
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2006
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-6-33

Other articles of this Issue 1/2006

BMC Complementary Medicine and Therapies 1/2006 Go to the issue

Research article

In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus

Research article

Catharanthus roseus flower extract has wound-healing activity in Sprague Dawley rats

Research article

Use of selected complementary and alternative medicine (CAM) treatments in veterans with cancer or chronic pain: a cross-sectional survey

Research article

Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity™ (PSP)

Research article

Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review

Research article

Dietary supplement use among health care professionals enrolled in an online curriculum on herbs and dietary supplements